The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma

The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma

Abstract Background Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are generally ignored. To explore alternative treatment options, we studied the e...

Full description

Bibliographic Details
Main Authors: Lu Xie, Xin Sun, Jie Xu, Xin Liang, Kuisheng Liu, Kunkun Sun, Rongli Yang, Xiaodong Tang, Wei Guo
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cancer
Subjects:
Epithelioid sarcoma
Systemic treatment
Objective response
Toxicity
Online Access:https://doi.org/10.1186/s12885-024-11921-7

Internet

https://doi.org/10.1186/s12885-024-11921-7

Similar Items